GPATCH4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.54082999999083E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
6.81179999961756E-07 |
Normal-vs-Stage2 |
4.418400E-03 |
Normal-vs-Stage3 |
2.481600E-01 |
Normal-vs-Stage4 |
3.627200E-01 |
Stage1-vs-Stage2 |
6.458000E-01 |
Stage1-vs-Stage3 |
8.949500E-02 |
Stage1-vs-Stage4 |
2.154800E-01 |
Stage2-vs-Stage3 |
1.745580E-01 |
Stage2-vs-Stage4 |
2.033800E-01 |
Stage3-vs-Stage4 |
9.630800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.770190E-04 |
Normal-vs-AfricanAmerican |
2.80480000336425E-08 |
Normal-vs-Asian |
4.063600E-01 |
Caucasian-vs-AfricanAmerican |
1.006380E-02 |
Caucasian-vs-Asian |
8.015000E-01 |
AfricanAmerican-vs-Asian |
8.775800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.08010000002368E-07 |
Normal-vs-Female |
1.608620E-01 |
Male-vs-Female |
1.235530E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.397390E-03 |
Normal-vs-Extreme_Weight |
1.5262799999971E-05 |
Normal-vs-Obese |
3.380300E-03 |
Normal-vs-Extreme_Obese |
1.833860E-02 |
Normal_Weight-vs-Extreme_Weight |
8.280400E-01 |
Normal_Weight-vs-Obese |
5.205000E-01 |
Normal_Weight-vs-Extreme_Obese |
7.099800E-01 |
Extreme_Weight-vs-Obese |
2.990400E-01 |
Extreme_Weight-vs-Extreme_Obese |
7.680800E-01 |
Obese-vs-Extreme_Obese |
4.349400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
9.068000E-01 |
Normal-vs-Age(41-60Yrs) |
1.95070999999825E-05 |
Normal-vs-Age(61-80Yrs) |
5.63969999999303E-05 |
Normal-vs-Age(81-100Yrs) |
8.53940000045128E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.328570E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.633440E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.834490E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.852600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.310000E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.499800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
2.2828000001418E-07 |
Normal-VS-Type2 PRCC |
4.761900E-03 |
Normal-VS-KIRP CIMP |
9.122000E-01 |
Normal-VS-Unclassified PRCC |
2.363600E-02 |
Type1 PRCC-VS-Type2 PRCC |
1.908400E-01 |
Type1 PRCC-VS-KIRP CIMP |
2.999800E-01 |
Type1 PRCC-VS-Unclassified PRCC |
2.460000E-01 |
Type2 PRCC-VS-KIRP CIMP |
4.773600E-01 |
Type2 PRCC-VS-Unclassified PRCC |
9.277000E-01 |
KIRP CIMP-VS-Unclassified PRCC |
5.062400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.43439999994644E-06 |
Normal-vs-N1 |
6.166600E-01 |
Normal-vs-N2 |
7.480400E-01 |
N0-vs-N1 |
9.458800E-03 |
N0-vs-N2 |
2.578800E-01 |
N1-vs-N2 |
6.408800E-01 |
|
|